Retrospective cohort study reveals significant variability in CD4+ T-cell counts among treated individuals with suppressed HIV, indicating potential health concerns.
Introduction Few published reports describe individual trajectories or heterogeneity in CD4+ T-cell count trends over time among virologically suppressed people living with HIV (PLWH). Methods We conducted a retrospective cohort study using administrative health claims among adults aged 18-65 years with a viral load of ≤ 200 copies/mL between January 1, 2012, and June 30, 2022. Among individuals with at least four CD4+ T-cell measurements, we described the proportion of individuals with both transient and sustained changes in cell counts of more than 30% overall. We stratified by baseline CD4+ T-cell count. Results A 30% increase or decrease from baseline was observed in 48.2% and 18.8% of individuals at a mean of 53.0 and 55.6 weeks of follow-up, respectively. Of people with a 30% decrease, 38.4% had at least two subsequent T-cell counts, and 24.3% did not return to within 30% of their baseline value. Discussion CD4+ T-cell counts continue to vary significantly after a year of suppressed viral load among people living with HIV. The proportion of PLWH with more than a 30% increase was more than twice that of those with more than a 30% decrease; a sustained decrease in CD4+ T-cell count was observed for 1.8% of the full cohort while they continued to be virally suppressed. Conclusion There is meaningful heterogeneity in CD4+ T-cell count trajectories, including significant drops while remaining virally suppressed, among PLWH with suppressed viral load that is infrequently described.
No takes yet. Share an insight, caveat, or question.
Mott et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: